Nispore PFS-35 ml

Adult (Oral)-Vaginal Candidiasis: 150 mg as a Single Dose.
Oropharyngeal Candidiasis: 200 mg on the First Day, Followed by 100 mg Once Daily. Clinical Evidence of this Infection Generally Resolves within Several Days, but Treatment should be Continued for at Least 2 Weeks to Decrease the Likelihood of Relapse.
Esophageal Candidiasis: 200 mg on the First Day, Followed by 100 mg Once Daily. Doses Up to 400 mg/day may be Used. Patients should be Treated for a Minimum of Three Weeks and for at Least Two Weeks Following Resolution of Symptoms.
Systemic Candida Infections: Optimal Therapeutic Dosage and Duration of Therapy have not been Established. Sometimes, Doses of Up to 400 mg Daily have been Used.
Urinary Tract Infections Caused by Candida and Peritonitis: 50-200 mg Daily have been Used.
Cryptococcal Meningitis: 400 mg on the First Day, Followed by 200 mg Once Daily.
Prophylaxis in Patients Undergoing bone Marrow Transplantation: 400 mg Once Daily.
Child (Oral): Doses of 3-6 mg/kg Daily have been used. Doses Up to 12 mg/kg is Recommended.